Term
| What do ACE-I drugs generally end in? |
|
Definition
|
|
Term
| What do angiotensin receptor blocker drugs generally end in? |
|
Definition
|
|
Term
| What do aldosterone blocking drugs generally end in? |
|
Definition
|
|
Term
| What do beta-blocking drugs generally end in? |
|
Definition
|
|
Term
| What does hemostasis mean? |
|
Definition
|
|
Term
| Type of Drug: clopidogrel |
|
Definition
| thienopyridine (antiplatelet) |
|
|
Term
| Name the antiplatelet GPIIb/IIIa blocker drugs |
|
Definition
| abciximab, eptifibatide, tirofiban |
|
|
Term
|
Definition
| antiplatelet (GPIIb/IIIa blocker) |
|
|
Term
| Type of drug: eptifibatide |
|
Definition
| antiplatelet (GPIIb/IIIa blocker) |
|
|
Term
|
Definition
| antiplatelet (GPIIb/IIIa blocker) |
|
|
Term
| Type of drug? Fondaparinux |
|
Definition
| Antithrombotic: antithrombin: heparin analog. Binds to antithrombin; block factor X in clotting cascade but has no effect on thrombin. |
|
|
Term
|
Definition
| Antithrombotic: antithrombin: direct thrombin inhibitor |
|
|
Term
| Type of drug? bivalarudin |
|
Definition
| Antithrombotic: antithrombin: direct thrombin inhibitor |
|
|
Term
|
Definition
| Antithrombotic: antithrombin: direct thrombin inhibitor |
|
|
Term
|
Definition
| Antithrombotic: antithrombin: Vitamin K antagonist (not exactly sure how being a vitamin K antagonist means you are antithrombin) |
|
|
Term
|
Definition
| Antithrombotic: thrombolytic agent (plasminogen activator) |
|
|
Term
| Type of drug? tenecteplase |
|
Definition
| Antithrombotic: thrombolytic agent (plasminogen activator) |
|
|
Term
|
Definition
| Antithrombotic: thrombolytic agent (plasminogen activator) |
|
|
